Rucaparib Improves PFS in Advanced Ovarian Cancer
Oncology Nursing News,
First-line maintenance treatment with rucaparib (Rubraca) significantly improved progression-free survival (PFS) among patients…
ATHENA (GOG-3020/ENGOT-ov45): a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA–MONO) and rucaparib in combination with nivolumab (ATHENA–COMBO) as maintenance treatment…
Overview of attention for article published in International Journal of Gynecological Cancer, September 2021
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (81st percentile)
-
Good Attention Score compared to outputs of the same age and source (77th percentile)
Readers on
- mendeley
- 82 Mendeley